Advanced search
Publication Cover
Developmental Neurorehabilitation Volume 23, 2020 - Issue 6
Submit an article Journal homepage
4,610
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Upper-extremity Spasticity-reducing Treatment in Adjunct to Movement Training and Orthoses in Children with Cerebral Palsy at Gross Motor Function- and Manual Ability Classification System Levels IV-V: A Descriptive Study

Gerd Anderssona Habilitation Centre, Västerbotten County Council, Umeå, SwedenView further author information
,
Barbro Renströma Habilitation Centre, Västerbotten County Council, Umeå, SwedenView further author information
,
Izabela Blaszczykb Department of Surgical and Perioperative Sciences, Hand and Plastic Surgery, Umeå University, Umeå, SwedenView further author information
&
Erik Domellöfa Habilitation Centre, Västerbotten County Council, Umeå, Sweden;b Department of Surgical and Perioperative Sciences, Hand and Plastic Surgery, Umeå University, Umeå, Sweden;c Department of Psychology, Umeå University, Umeå, SwedenCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-0240-3690View further author information
ORCID Icon
Pages 349-358 | Received 29 Mar 2019, Accepted 10 Aug 2019, Published online: 22 Aug 2019

References

  • Bax M, Goldstein M, Rosenbaum P, Leviton A, Paneth N, Dan B, Jacobsson B, Damiano D. Proposed definition and classification of cerebral palsy, April 2005. Dev Med Child Neurol. 2005;47:571–76.
  • Cans C. Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers. Dev Med Child Neurol. 2000;42:816–24.
  • Himmelmann K, Beckung E, Hagberg G, Uvebrant P. Gross and fine motor function and accompanying impairments in cerebral palsy. Dev Med Child Neurol. 2006;49:417–23. doi:10.1017/S0012162206000922.
  • Rosenbaum P, Paneth N, Leviton A, Goldstein M, Bax M, Damiano D, Dan B, Jacobsson B. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol. 2007;Suppl.109:8–14.
  • Westbom L, Bergstrand L, Wagner P, Nordmark E. Survival at 19 years of age in a total population of children and young people with cerebral palsy. Dev Med Child Neurol. 2011;53:808–14. doi:10.1111/j.1469-8749.2011.04027.x.
  • Hoare BJ, Wallen MA, Imms C, Villanueva E, Rawicki HB, Carey L. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE). Cochrane Database Syst Rev. 2010;1:CD003469.
  • Novak I, McIntyre S, Morgan C, Campbell L, Dark L, Morton N, Stumbles E, Wilson SA, Goldsmith S. A systematic review of interventions for children with cerebral palsy: state of the evidence. Dev Med Child Neurol. 2013;55:885–910. doi:10.1111/dmcn.12246.
  • Pin TW, Elmasry J, Lewis J. Efficacy of botulinum toxin A in children with cerebral palsy in gross motor function classification system levels IV and V: a systematic review. Dev Med Child Neurol. 2013;55:304–13. doi:10.1111/j.1469-8749.2012.04438.x.
  • Mesterman R, Gorter JW, Harvey A, Lockhart J, McEwen-Hill J, Margallo K, Goldie N. Botulinum toxic type A in children and adolescents with severe cerebral palsy: a retrospective chart review. J Child Neurol. 2014;29:210–13. doi:10.1177/0883073813495306.
  • Copeland L, Edwards P, Thorley M, Donaghey S, Gascoigne-Pees L, Kentish M, Cert G, Lindsley J, McLennan K, Sakzewski L, et al. Botulinumtoxin A for nonambulatory children with cerebral palsy: a double blinded randomized controlled trial. J Pedriatr. 2014;165:140–46. doi:10.1016/j.jpeds.2014.01.050.
  • Lee JS, Lee KB, Lee YR, Choi YN, Park CW, Park SD, Jung DH, Lee CS. Botulinum toxin treatment on upper limb function in school age children with bilateral spastic palsy: one year follow-up. Ann Rehabil Med. 2013;37:328–35. doi:10.5535/arm.2013.37.3.328.
  • Yelnik AP, Simon O, Parratte B, Gracies JM. How to clinically assess and treat muscle overactivity in spastic paresis. J Rehabil Med. 2010;42:801–07. doi:10.2340/16501977-0613.
  • Wilton J. Casting, splinting, and physical and occupational therapy of hand deformity and dysfunction in cerebral palsy. Hand Clin. 2003;19:573–84.
  • Norkin CC, White DJ. Measurement of joint motion: a guide to goniometry. Philadelphia (PA/US): Davis; 1985.
  • Hedberg-Graff J, Granström F, Arner M, Krumlinde-Sundholm L. Upper-limb contracture development in children with cerebral palsy: a population-based study. Dev Med Child Neurol. 2019;61:204–2011. doi:10.1111/dmcn.14006.
  • CPUP. Cerebral palsy follow-up program Annual report 2007. [ accessed 2019 Mar 13]. http://www.cpup.se.
  • House JH, Gwathmey FW, Fidler MO. A dynamic approach to the thumb-in palm deformity in cerebral palsy. J Bone Joint Surg Am. 1981;63:216–25.
  • CPUP. Critical values for passive joint range of motion. [ accessed 2019 Mar 13]. http://cpup.se/in-english/manuals-and-evaluation-forms/.
  • Sätilä H, Kotamäki A, Koivikko M, Autti-Rämö I. Upper limb function after botulinum toxin A treatment in cerebral palsy: two years follow-up of six cases. Pediatr Rehabil. 2006;9:247–58. doi:10.1080/13638490500523234.
  • Rösblad B, Andersson G, Pettersson K. Effects of botulinum toxin type A and a programme of functional activity to improve manual ability in children and adolescents with cerebral palsy. Scand J Plast Reconstr Surg Hand Surg. 2007;41:250–58. doi:10.1080/02844310701445560.
  • Blaszczyk I, Foumani NP, Ljungberg C, Wiberg M. Questionnaire about the adverse events and side effects following botulinum toxin A treatment in patients with cerebral palsy. Toxins. 2015;7:4645–54. doi:10.3390/toxins7114645.
  • Hoare B. Rationale for using botulinum toxin A as an adjunct to upper limb rehabilitation in children with cerebral palsy. J Child Neurol. 2014;29:1066–76. doi:10.1177/0883073814533196.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.